Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance
- PMID: 19320660
- DOI: 10.1111/j.1475-097X.2008.00851.x
Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance
Abstract
Background and aim: It has been reported that the endocardium in Fabry disease has a binary appearance on transthoracic echocardiography. It has been suggested that this sign could be used with good accuracy to differentiate Fabry disease from hypertrophic cardiomyopathy and even as a first filter to screen for suspected Fabry disease.
Methods: Therefore, we performed a blinded echocardiography in a non-selected population of patients with Fabry disease and matched controls. We included 23 echocardiographic studies of Fabry patients.
Results: Two of the Fabry patients had binary appearance of the endocardium. One of them had left ventricular hypertrophy (LVH) and the other had a normal left ventricular mass. Binary appearance of the endocardium was detected in four of the controls, and one of them had LVH. Subgroup analysis of patients who had LVH indicated a sensitivity of 12.5% and a specificity of 66.7% for binary appearance of the endocardium to detect Fabry disease as the underlying cause of LVH. Overall, binary appearance of the endocardium had a sensitivity and a specificity of 15.4 and 73.3%, respectively, to distinguish patients with Fabry disease from controls in our population.
Conclusions: Binary appearance of the endocardium is not feasible for screening Fabry disease by echocardiography.
Similar articles
-
The endocardial binary appearance ('binary sign') is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophy.Eur J Echocardiogr. 2011 Oct;12(10):744-9. doi: 10.1093/ejechocard/jer112. Epub 2011 Aug 20. Eur J Echocardiogr. 2011. PMID: 21857019
-
The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy.J Am Coll Cardiol. 2008 May 27;51(21):2058-61. doi: 10.1016/j.jacc.2008.02.046. J Am Coll Cardiol. 2008. PMID: 18498962
-
Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization.J Am Coll Cardiol. 2006 Apr 18;47(8):1663-71. doi: 10.1016/j.jacc.2005.11.070. Epub 2006 Mar 29. J Am Coll Cardiol. 2006. PMID: 16631007
-
An approach to echocardiography in hypertrophic cardiomyopathy and other causes of LVH.Minerva Cardioangiol. 2012 Apr;60(2):203-11. Minerva Cardioangiol. 2012. PMID: 22495169 Review.
-
The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease.JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1230-1242. doi: 10.1016/j.jcmg.2018.11.039. JACC Cardiovasc Imaging. 2019. PMID: 31272606 Review.
Cited by
-
The subaortic tendon as a mimic of hypertrophic cardiomyopathy.Cardiovasc Ultrasound. 2009 Jul 3;7:31. doi: 10.1186/1476-7120-7-31. Cardiovasc Ultrasound. 2009. PMID: 19573250 Free PMC article.
-
Role of standard echocardiography in Anderson-Fabry disease.Front Cardiovasc Med. 2024 Oct 24;11:1467815. doi: 10.3389/fcvm.2024.1467815. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39526187 Free PMC article. Review.
-
Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy.Cardiovasc J Afr. 2011 Jan-Feb;22(1):38-44. Cardiovasc J Afr. 2011. PMID: 21298206 Free PMC article. Review.
-
Deposit Diseases as Differential Diagnosis of Left Ventricular Hypertrophy in Patients with Heart Failure and Preserved Systolic Function.Arq Bras Cardiol. 2019 Nov;113(5):979-987. doi: 10.36660/abc.20180370. Arq Bras Cardiol. 2019. PMID: 31800724 Free PMC article. Review. No abstract available.
-
GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?Arq Bras Cardiol. 2019 Jul 10;113(1):77-84. doi: 10.5935/abc.20190112. Arq Bras Cardiol. 2019. PMID: 31291414 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical